Nasdaq
SLXN
Silexion Therapeutics Corp
- Health Care
- Israel
- 1 day
- −0.6%
- 1 month
- −34.7%
- 1 year
- −97.8%
$1.79 · Mkt cap $1.90M
At the 6 Aug 2026 close
Nasdaq
Silexion Therapeutics Corp
$1.79 · Mkt cap $1.90M
At the 6 Aug 2026 close
Silexion Therapeutics Corp trades under the ticker SLXN on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $1.90M. The last closing price was $1.79, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −97.8%, and −34.7% over the past month. Returns are price returns and exclude dividends.
This page exists because SLXN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.